From: Nephrotoxic drug burden among 1001 critically ill patients: impact on acute kidney injury
Variables | N = 1001 patients |
---|---|
Female gender | 362 (36%) |
Age (years) | 65 ± 16 |
Main admission diagnosis | |
De novo acute respiratory failure | 182 (18%) |
Coma, seizure | 153 (15%) |
Sepsis and septic shock | 150 (15%) |
Chronic respiratory failure exacerbation | 139 (14%) |
Cardiac arrest | 95 (10%) |
Hemorrhagic and hypovolemic shock | 34 (3%) |
Cardiogenic shock | 31 (3%) |
Post-operative monitoring | 27 (3%) |
Acute renal failure | 14 (1%) |
Other | 175 (18%) |
Admission origin | |
Emergency department | 388 (39%) |
Ward | 433 (43%) |
Home | 179 (18%) |
Simplified acute physiology score 2 | 47 ± 20 |
Invasive mechanical ventilation | 617 (62%) |
Co-morbidities | |
Arterial hypertension | 513 (51%) |
Diabetes mellitus | 236 (24%) |
Chronic respiratory failure | 206 (21%) |
Ischemic heart disease | 161 (16%) |
Chronic heart failure | 122 (12%) |
Peripheral artery disease | 115 (12%) |
Chronic kidney disease | 96 (10%) |
Cirrhosis | 47 (5%) |
Outcomes | |
Intensive-care unit mortality | 235 (24%) |
Hospital mortality | 285 (29%) |
Intensive-care unit lengths of stay (days) | 4 [2, 7] |
Hospital lengths of stay (days) | 10 [4, 21] |